X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
glycopyrronium (274) 274
index medicus (183) 183
humans (174) 174
copd (127) 127
respiratory system (126) 126
tiotropium (120) 120
female (113) 113
male (108) 108
obstructive pulmonary-disease (106) 106
chronic obstructive pulmonary disease (103) 103
pulmonary disease, chronic obstructive - drug therapy (103) 103
indacaterol (90) 90
middle aged (83) 83
lung diseases, obstructive (82) 82
glycopyrrolate - administration & dosage (72) 72
treatment outcome (72) 72
bronchodilator agents - administration & dosage (69) 69
muscarinic antagonists - administration & dosage (67) 67
aged (66) 66
double-blind (65) 65
administration, inhalation (63) 63
pharmacology & pharmacy (59) 59
pulmonary disease, chronic obstructive - physiopathology (58) 58
safety (58) 58
adult (53) 53
efficacy (53) 53
bronchodilator agents - adverse effects (52) 52
double-blind method (51) 51
exacerbations (50) 50
glycopyrronium bromide (50) 50
muscarinic antagonists - adverse effects (49) 49
glycopyrrolate - adverse effects (46) 46
pulmonary disease, chronic obstructive - diagnosis (45) 45
anesthesiology (44) 44
diseases of the respiratory system (43) 43
glycopyrrolate (43) 43
drug therapy (42) 42
dosage and administration (40) 40
drug combinations (38) 38
time factors (38) 38
adrenergic beta-2 receptor agonists - administration & dosage (36) 36
bronchodilator agents - therapeutic use (36) 36
drug therapy, combination (36) 36
glycopyrrolate - therapeutic use (36) 36
qva149 (36) 36
research (36) 36
severity of illness index (36) 36
analysis (35) 35
lung - drug effects (35) 35
lung - physiopathology (34) 34
care and treatment (33) 33
formoterol (33) 33
anesthesia (32) 32
indacaterol/glycopyrronium (32) 32
international journal of chronic obstructive pulmonary disease (31) 31
muscarinic antagonists - therapeutic use (31) 31
forced expiratory volume (30) 30
parallel-group (30) 30
bronchodilator (29) 29
salmeterol (29) 29
clinical trials (28) 28
indans - administration & dosage (27) 27
quinolones - administration & dosage (27) 27
respiratory tract diseases (27) 27
asthma (26) 26
glycopyrrolate - pharmacology (26) 26
original research (26) 26
adrenergic beta-2 receptor agonists - adverse effects (25) 25
patients (25) 25
aclidinium (24) 24
bronchodilators (23) 23
dual bronchodilation (23) 23
glycopyrrolate - pharmacokinetics (23) 23
combination (22) 22
cross-over studies (22) 22
drug administration schedule (22) 22
fluticasone (22) 22
lung-function (22) 22
placebo (22) 22
dose-response relationship, drug (21) 21
medicine, general & internal (21) 21
quality of life (21) 21
pharmacokinetics (20) 20
review (20) 20
comparative analysis (19) 19
dyspnea (19) 19
health aspects (19) 19
lung diseases (19) 19
salmeterol-fluticasone (19) 19
surgery (19) 19
therapy (19) 19
triple therapy (19) 19
management (18) 18
medical research (18) 18
tiotropium bromide (18) 18
bronchodilator agents - pharmacokinetics (17) 17
indans - adverse effects (17) 17
lama (17) 17
lung function (17) 17
mortality (17) 17
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (345) 345
Russian (5) 5
German (4) 4
Czech (3) 3
Korean (3) 3
French (2) 2
Italian (2) 2
Hungarian (1) 1
Polish (1) 1
Romanian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Trends in Anaesthesia and Critical Care, ISSN 2210-8440, 04/2019, Volume 25, pp. 38 - 40
Uncuffed tracheal tubes (TT) have historically been used in children under 8 years for fear of airway mucosal injury. Cuffed tubes are however useful for... 
Journal Article
Anaesthesiology Intensive Therapy, ISSN 1642-5758, 08/2017, Volume 49, Issue 3, pp. 242 - 243
Journal Article
Indian Journal of Anaesthesia, ISSN 0019-5049, 5/2018, Volume 62, Issue 5, pp. 400 - 402
Journal Article
Journal of Anaesthesiology Clinical Pharmacology, ISSN 0970-9185, 04/2015, Volume 31, Issue 2, pp. 280 - 281
Journal Article
Expert Review of Respiratory Medicine, ISSN 1747-6348, 01/2019, Volume 13, Issue 1, pp. 5 - 11
Introduction: The triple therapy term covers the combination of inhaled corticosteroid (ICS), long-acting β-receptor agonist (LABA) and long-acting... 
beclomethasone dipropionate | triple therapy | formoterol fumarate | glycopyrronium bromide | COPD | RESPIRATORY SYSTEM | PARALLEL-GROUP | DOUBLE-BLIND | EXACERBATIONS | EXTRAFINE GLYCOPYRRONIUM
Journal Article
Journal Article
NEW ENGLAND JOURNAL OF MEDICINE, ISSN 0028-4793, 08/2018, Volume 379, Issue 6, pp. 591 - 591
Journal Article
Journal of Clinical and Diagnostic Research, ISSN 2249-782X, 09/2016, Volume 10, Issue 9, pp. UC08 - UC12
Postoperative pain after thoracotomy is being considered one of the most severe pain and if not treated well, can result in various respiratory and other... 
Fentanyl | Bupivacaine | Painful surgeries | Anaesthesia Section
Journal Article
Pulmonary Pharmacology and Therapeutics, ISSN 1094-5539, 2014, Volume 28, Issue 2, pp. 114 - 121
This study characterised the invitro and invivo profiles of two novel long-acting muscarinic antagonists, aclidinium bromide and glycopyrronium bromide, using... 
SAMA | Raw | LAMA | Muscarinic receptors | Glycopyrronium bromide (PubChem CID: 11693) | Long-acting muscarinic antagonists | Aclidinium bromide (PubChem CID: 11519741) | Preclinical | Tiotropium bromide (PubChem CID: 5487426) | Aclidinium | Glycopyrronium | Ipratropium bromide (PubChem CID: 31098) | COPD
Journal Article
International Journal of COPD, ISSN 1176-9106, 2018, Volume 13, pp. 2319 - 2333
Journal Article
Advances in Therapy, ISSN 0741-238X, 3/2019, Volume 36, Issue 3, pp. 495 - 519
Maintenance bronchodilator therapy with long-acting β-agonists (LABAs) and long-acting muscarinic antagonists (LAMAs) is the cornerstone treatment for patients... 
Indacaterol/glycopyrronium | Rheumatology | Internal Medicine | Oncology | Olodaterol/tiotropium | Medicine & Public Health | Asia | Fixed-dose combination | Formoterol/aclidinium | Vilanterol/umeclidinium | Long-acting muscarinic antagonists | Long-acting β-agonists | Chronic obstructive pulmonary disease | Cardiology | Pharmacology/Toxicology | Endocrinology | MEDICINE, RESEARCH & EXPERIMENTAL | Long-acting beta-agonists | PHARMACOLOGICAL CHARACTERIZATION | QVA149 INDACATEROL/GLYCOPYRRONIUM | OBSTRUCTIVE PULMONARY-DISEASE | ACLIDINIUM BROMIDE | 5 MU-G | ONCE-DAILY INDACATEROL | TWICE-DAILY SALMETEROL | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | JAPANESE PATIENTS | CHINESE PATIENTS | Bronchodilator Agents - therapeutic use | Bronchodilator Agents - administration & dosage | Humans | Muscarinic Antagonists - adverse effects | Muscarinic Antagonists - therapeutic use | Benzyl Alcohols - therapeutic use | Indans - therapeutic use | Quinuclidines - therapeutic use | Adrenergic beta-2 Receptor Agonists - adverse effects | Quinolones - therapeutic use | Adrenergic beta-2 Receptor Agonists - therapeutic use | Tiotropium Bromide - therapeutic use | Bronchodilator Agents - adverse effects | Formoterol Fumarate - therapeutic use | Glycopyrrolate - therapeutic use | Administration, Inhalation | Treatment Outcome | Tropanes - therapeutic use | Benzoxazines - therapeutic use | Muscarinic Antagonists - administration & dosage | Asian Continental Ancestry Group | Chlorobenzenes - therapeutic use | Adrenergic beta-2 Receptor Agonists - administration & dosage | Drug Combinations | Pulmonary Disease, Chronic Obstructive - drug therapy | aclidinium | umeclidinium | Indacaterol | Review | tiotropium | Vilanterol | Formoterol | glycopyrronium | Olodaterol
Journal Article
Respiration, ISSN 0025-7931, 04/2018, Volume 95, Issue Suppl 1, pp. 6 - 10
We present the case of a 77-year-old man diagnosed with chronic obstructive pulmonary disease (COPD) stage D with emphysema phenotype and treated with triple... 
Case Report | Chronic obstructive pulmonary disease | GOLD stage | Ventilatory response to exercise | Indacaterol/ glycopyrronium | MILD | Indacaterol/glycopyrronium | DIAGNOSIS | MANAGEMENT | RESPIRATORY SYSTEM | CONSTRAINTS | EXERCISE | COPD | Tiotropium | Medical research | Lung diseases, Obstructive | Medicine, Experimental | Development and progression | Indacaterol | Fluticasone
Journal Article
Respiratory Research, ISSN 1465-9921, 07/2017, Volume 18, Issue 1, pp. 140 - 9
Background: Dual bronchodilation combining a long-acting beta(2)-agonist (LABA) and a long-acting muscarinic antagonist (LAMA) is the preferred choice of... 
Indacaterol/glycopyrronium | Open-label | Chronic obstructive pulmonary disease | Dual bronchodilation | Direct switch | INDACATEROL | MULTICENTER | QVA149 | SALMETEROL-FLUTICASONE | SALMETEROL/FLUTICASONE | OBSTRUCTIVE PULMONARY-DISEASE | RESPIRATORY SYSTEM | DOUBLE-BLIND | EXACERBATIONS | TIOTROPIUM | GLYCOPYRRONIUM | Indans - adverse effects | Prospective Studies | Bronchodilator Agents - administration & dosage | Humans | Middle Aged | Muscarinic Antagonists - adverse effects | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | Recovery of Function | Forced Expiratory Volume | Quinolones - adverse effects | Time Factors | Adrenergic beta-2 Receptor Agonists - adverse effects | Patient Safety | Adult | Female | Indans - administration & dosage | Bronchodilator Agents - adverse effects | Glycopyrrolate - adverse effects | Severity of Illness Index | Pulmonary Disease, Chronic Obstructive - diagnosis | Dyspnea - diagnosis | Europe | Risk Factors | Treatment Outcome | Dyspnea - physiopathology | Lung - physiopathology | Disease Progression | Muscarinic Antagonists - administration & dosage | Quinolones - administration & dosage | Glycopyrrolate - administration & dosage | Lung - drug effects | Quality of Life | Adrenergic beta-2 Receptor Agonists - administration & dosage | Dyspnea - drug therapy | Aged | Drug Substitution | Health Status | Pulmonary Disease, Chronic Obstructive - drug therapy | Complications and side effects | Lung diseases, Obstructive | Corticosteroids | Patient outcomes | Dosage and administration | Indacaterol | Drug therapy, Combination | Research | Drug therapy | Performance evaluation | Bronchodilation | Drugs | Medical research | Gold | Respiratory function | Acetylcholine receptors (muscarinic) | Control methods | Lung diseases | Clinical trials | Disease control | Patients | Primary care | Randomization | Dyspnea | Motivation | Obstructive lung disease | Clinical medicine | Safety | Respiration | glycopyrronium
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 01/2019, Volume 80, Issue 1, pp. 128 - 138.e2
Glycopyrronium tosylate (GT) is a topical anticholinergic developed for once-daily treatment of primary axillary hyperhidrosis. Assess the efficacy and safety... 
hyperhidrosis | glycopyrronium tosylate | DRM04 | cholinergic receptor | sweat | axilla | anticholinergic | DIAGNOSIS | EFFICACY | RECOGNITION | PREVALENCE | DERMATOLOGY | INDIVIDUALS | SEVERITY | Clinical trials | Care and treatment | Hyperhidrosis
Journal Article
International journal of chronic obstructive pulmonary disease, ISSN 1176-9106, 2019, Volume 14, pp. 249 - 260
Purpose: In contrast to randomized controlled trials (RCTs), changes in maintenance pharmacotherapy in clinical practice occur without a washout period. The... 
Indacaterol/glycopyrronium | Dyspnea | Lung function | COPD assessment test | FEV | TDI | FEV1 | VILANTEROL | INHALED CORTICOSTEROIDS | QVA149 | RISK | dyspnea | SALMETEROL-FLUTICASONE | OBSTRUCTIVE PULMONARY-DISEASE | lung function | RESPIRATORY SYSTEM | DUAL BRONCHODILATION | DOUBLE-BLIND | EXACERBATIONS | TRIPLE THERAPY | indacaterol/glycopyrronium | Salmeterol/fluticasone | Tiotropium
Journal Article
Respiratory Research, ISSN 1465-9921, 06/2018, Volume 19, Issue 1, pp. 121 - 8
Journal Article